Exscientia enters strategic drug discovery collaboration with GSK
Pre-clinical collaboration focused on up to 10 targets
03-Jul-2017 -
Exscientia, a company for Artificial Intelligence (AI)-driven drug discovery, announces it has entered into a strategic drug discovery collaboration with GlaxoSmithKline (GSK). During this collaboration, Exscientia will apply its AI enabled platform and combine this with the expertise of GSK, in ...
artificial intelligence
computer-aided drug design
drug candidates
+4